Gardasil Clears Safety Review: No Link To VTE, Mini-Sentinel Study Finds
This article was originally published in The Pink Sheet Daily
Study finds no increased risk of venous thromboembolism in more than 650,000 females vaccinated with the HPV vaccine; no labeling changes requested by FDA.
You may also be interested in...
Emergent reveals acquisition of GSK's anthrax therapy raxibacumab days after a vaccine deal with Sanofi. Telix licenses PSMA antibodies from Abzena, while PeptiDream and Kleo sign an immuno-oncology pact.
Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.
Benefits of the one-shot vaccine outweigh risk, ACIP members agree. One member says he supports its availability but would personally recommend mRNA vaccines instead.